Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and advanced kidney disease.

Chia-Chen HsuCheng-Chi ChenChian-Ying ChouKuan-Hsuan ChenSheng-Fan WangShih-Lin ChangYuh-Lih Chang

Published in: Journal of thrombosis and thrombolysis (2023)

Among patients with AF and AKD, DOACs were linked to a lower risk of ischemic events, and apixaban was linked to a lower risk of any ischemia and any bleeding than warfarin.

Keyphrases

direct oral anticoagulants
atrial fibrillation
venous thromboembolism
oral anticoagulants
oxidative stress
blood brain barrier